12月9日，康臣药业(01681)盘中上涨5.6%，截至15:56，报8.3元/股，成交1279.27万元。
康臣药业集团是一家制药企业，以研发、生产和营销肾科、影像、妇儿、骨伤、皮肤、肝胆、消化系列药品为主要业务，拥有138个品种药品，其中33个品种进入国家基本药物目录，67个品种进入国家医保目录。康臣药业的关键经营数据表现在其当下拥有广东广州、内蒙古通辽、广西玉林、新疆霍尔果斯等4个生产基地，员工逾3000人，且其分销网络遍布全国，业绩长期保持稳定高速增长。
截至2024年中报，康臣药业营业总收入12.69亿元、净利润4.0亿元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.